Legal & General Group’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.73M | Sell |
61,236
-347
| -0.6% | -$16.5K | ﹤0.01% | 1838 |
|
|
2026
Q1 | $3.18M | Sell |
61,583
-8,173
| -12% | -$572K | ﹤0.01% | 1720 |
|
|
2025
Q4 | $6.43M | Sell |
69,756
-14,524
| -17% | -$1.39M | ﹤0.01% | 1425 |
|
|
2025
Q3 | $6.25M | Sell |
84,280
-11,408
| -12% | -$1.16M | ﹤0.01% | 1440 |
|
|
2025
Q2 | $12.4M | Buy |
95,688
+1,709
| +2% | +$248K | ﹤0.01% | 1082 |
|
|
2025
Q1 | $15M | Sell |
93,979
-1,499
| -2% | -$271K | ﹤0.01% | 926 |
|
|
2024
Q4 | $17.7M | Buy |
95,478
+3,065
| +3% | +$595K | ﹤0.01% | 876 |
|
|
2024
Q3 | $19.5M | Buy |
92,413
+51,895
| +128% | +$9.02M | 0.01% | 851 |
|
|
2024
Q2 | $5.42M | Buy |
40,518
+10,788
| +36% | +$2.04M | ﹤0.01% | 1484 |
|
|
2024
Q1 | $6.39M | Buy |
29,730
+991
| +3% | +$194K | ﹤0.01% | 1392 |
|
|
2023
Q4 | $5.85M | Sell |
28,739
-10,038
| -26% | -$1.63M | ﹤0.01% | 1425 |
|
|
2023
Q3 | $7.69M | Sell |
38,777
-974
| -2% | -$246K | ﹤0.01% | 1201 |
|
|
2023
Q2 | $12.9M | Buy |
39,751
+5,164
| +15% | +$1.48M | ﹤0.01% | 983 |
|
|
2023
Q1 | $8.1M | Buy |
34,587
+1,733
| +5% | +$438K | ﹤0.01% | 1159 |
|
|
2022
Q4 | $8.28M | Buy |
32,854
+274
| +0.8% | +$58.4K | ﹤0.01% | 1151 |
|
|
2022
Q3 | $5.78M | Sell |
32,580
-677
| -2% | -$136K | ﹤0.01% | 1299 |
|
|
2022
Q2 | $6.08M | Buy |
33,257
+8,896
| +37% | +$1.77M | ﹤0.01% | 1322 |
|
|
2022
Q1 | $6.25M | Buy |
24,361
+398
| +2% | +$91K | ﹤0.01% | 1397 |
|
|
2021
Q4 | $5.51M | Buy |
23,963
+55
| +0.2% | +$13.4K | ﹤0.01% | 1519 |
|
|
2021
Q3 | $5.57M | Buy |
23,908
+6,412
| +37% | +$1.34M | ﹤0.01% | 1492 |
|
|
2021
Q2 | $3.38M | Buy |
17,496
+224
| +1% | +$44.4K | ﹤0.01% | 1730 |
|
|
2021
Q1 | $3.58M | Sell |
17,272
-758
| -4% | -$161K | ﹤0.01% | 1737 |
|
|
2020
Q4 | $3.39M | Buy |
18,030
+2,185
| +14% | +$357K | ﹤0.01% | 1674 |
|
|
2020
Q3 | $2.04M | Buy |
15,845
+8,752
| +123% | +$964K | ﹤0.01% | 1754 |
|
|
2020
Q2 | $617K | Buy |
7,093
+4,467
| +170% | +$343K | ﹤0.01% | 2121 |
|
|
2020
Q1 | $159K | Sell |
2,626
-604
| -19% | -$44.7K | ﹤0.01% | 2319 |
|
|
2019
Q4 | $240K | Buy |
3,230
+542
| +20% | +$34.8K | ﹤0.01% | 2353 |
|
|
2019
Q3 | $164K | Sell |
2,688
-137
| -5% | -$9.02K | ﹤0.01% | 2389 |
|
|
2019
Q2 | $171K | Hold |
2,825
| – | – | ﹤0.01% | 2393 |
|
|
2019
Q1 | $160K | Buy |
2,825
+982
| +53% | +$53.1K | ﹤0.01% | 2372 |
|
|
2018
Q4 | $78K | Buy |
1,843
+674
| +58% | +$28.7K | ﹤0.01% | 2528 |
|
|
2018
Q3 | $49K | Hold |
1,169
| – | – | ﹤0.01% | 2782 |
|
|
2018
Q2 | $42K | Buy |
+1,169
| New | +$37.7K | ﹤0.01% | 2831 |
|
Other funds holding INSP
SCM
DM
Legal & General Group's INSP Position: Q2 2026 in Review
Legal & General Group reduced its Inspire Medical Systems (INSP) stake by 0.56% in Q2 2026, selling an estimated $16.5K and leaving 61,236 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1838.
Legal & General Group first reported a position in INSP in Q2 2018 and has held it in 33 quarters since. The position peaked at $19.5M in Q3 2024. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.
- Legal & General Group held 61,236 shares of Inspire Medical Systems worth $2.73M as of Q2 2026.
- Legal & General Group sold 347 Inspire Medical Systems shares in Q2 2026, an estimated $16.5K.
- Inspire Medical Systems made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1838 holding.
- Legal & General Group first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 33 quarters since.
- Legal & General Group's Inspire Medical Systems position peaked at $19.5M in Q3 2024.
- 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.